XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Acquisitions (Tables)
9 Months Ended
Sep. 30, 2025
Acquisitions  
Schedule of preliminary purchase price and allocation

The preliminary purchase price consideration consists of the Company’s shares of common stock issued as of the Closing Date and the additional stock-based compensation related to the fair value of replacement awards attributable to pre-combination services, and is calculated as follows (in thousands, except share and per share data):

Implied shares of common stock issued to holders of ACELYRIN common stock

48,653,549

Closing price per share of common stock as of Closing Date

$

4.78

Consideration transferred for share exchange

$

232,564

Fair value of replacement awards attributable to pre-combination services

$

5,513

Total preliminary purchase price consideration

$

238,077

The following table presents the preliminary purchase price allocation of the fair value of the net assets acquired and liabilities assumed as of the Closing Date (in thousands):

Assets Acquired

 

  

Cash and cash equivalents

$

49,155

Restricted cash

 

367

Marketable securities

 

333,436

Research and development prepaid expenses

 

958

Prepaid credit voucher for clinical manufacturing

11,376

Other prepaid expenses and current assets

 

8,081

Restricted cash, non-current

 

220

Property and equipment, net

 

420

Intangible assets

50,959

Operating lease right-of-use assets, net

 

4,349

Other assets, non-current

 

744

Total assets

$

460,065

Liabilities Assumed

 

  

Accounts payable

$

(6,518)

Research and development accrued expenses

 

(3,546)

Other accrued expenses and current liabilities

 

(5,688)

Operating lease liabilities, current

 

(1,390)

Operating lease liabilities, non-current

 

(6,238)

Deferred income tax liability

 

(10,701)

Total liabilities

 

(34,081)

Fair value of net assets

$

425,984

Purchase consideration

238,077

Gain on bargain purchase

$

187,907

Schedule of pro forma information

    

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2025

2024

2025

    

2024

Total revenue

$

2,066

$

$

22,121

$

Net income (loss)

(104,452)

(141,667)

(380,973)

(222,102)